Furthermore, CAAs are characterized by decreased differentiation markers of mature adipocytes and a more aggressive secretome depending on the overexpression of inflammatory cytokines and proteases, aberrant secretion of adipokines (such as leptin and adiponectin), and promotion of metabolic reprogramming of breast cancer cells [6,90,93]. The gene discussed is ADIPOQ; the disease is breast cancer.